產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CD170抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CD170抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CD170
Cat. Number:
Anti-CD170抗體KL-2703R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Putative adhesion molecule Anti-CD170抗體that mediates sialic-acid dependent binding to cells. Binds equally to alpha2,3-linked and alpha2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. This molecule is expressed by monocytic/myeloid lineage cells. Found at high levels in peripheral blood leukocytes, spleen, bone marrow and at lower levels in lymph node, lung, appendix, placenta, pancreas and thymus. Expressed by monocytes and neutrophils but absent from leukemic cell lines representing early stages of myelomonocytic differenciation.
Also known as:
SIGLEC5; CD170 antigen; Anti-CD170抗體CD33 antigen-like 2; CD33L2; mSiglec-F;OB-binding protein 2; OB-BP2; OBBP2; Obesity-binding protein 2; Sialic acid binding Ig-like lectin 5; Sialic acid binding immunoglobulin-like lectin 5; Sialic acid-binding Ig-like lectin F; SIGLEC-5; Siglec-F variant; Siglecf; SIGL5_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CD170.
●
Predicted Molecular WeightAnti-CD170抗體: 59kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must Anti-CD170抗體be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must Anti-CD170抗體be determined by the end user.
kl087Rb21 單核細(xì)胞趨化蛋白1(MCP1)多克隆抗體 Polyclonal Antibody to Monocyte Chemotactic Protein 1 (MCP1)
kl262Mu01 整合素β3(ITGβ3)多克隆抗體 Polyclonal Antibody to Integrin Beta 3 (ITGb3)
kl033Gu01 干擾素α(IFNα)多克隆抗體 Polyclonal Antibody to Interferon Alpha (IFNa)
kl238Po01 酪氨酸酶(TYR)多克隆抗體 Polyclonal Antibody to Tyrosinase (TYR)
kl815Ra03 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 1, Neuronal (NOS1)
kl099Ra01 CD8a分子(CD8a)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 8a (CD8a)
kl331Mu01 套膜蛋白(iNV)多克隆抗體 Polyclonal Antibody to Involucrin (iNV)
kl975Ra03 肌腱蛋白C(TNC)多克隆抗體 Polyclonal Antibody to Tenascin C (TNC)
kl166Bo01 Ⅱ類(lèi)主要組織相容性復(fù)合體DRα(MHCDRα)多克隆抗體 Polyclonal Antibody to Major Histocomklibility Complex Class II DR Alpha (MHCDRa)
kl166Ca01 Ⅱ類(lèi)主要組織相容性復(fù)合體DRα(MHCDRα)多克隆抗體 Polyclonal Antibody to Major Histocomklibility Complex Class II DR Alpha (MHCDRa)
kl463Mu02 內(nèi)皮細(xì)胞特異分子1(ESM1)多克隆抗體 Polyclonal Antibody to Endothelial Cell Specific Molecule 1 (ESM1)
kl427Hu01 肌球蛋白輕鏈4(MYL4)多克隆抗體 Polyclonal Antibody to Myosin Light Chain 4, Alkali, Atrial, Embryonic (MYL4)
kl454Hu01 肌球蛋白重鏈14(MYH14)多克隆抗體 Polyclonal Antibody to Myosin Heavy Chain 14, Non Muscle (MYH14)
kl175Ra01 干擾素α4(IFNα4)多克隆抗體 Polyclonal Antibody to Interferon Alpha 4 (IFNa4)
kl177Ra01 酸性葡糖苷酶α(GαA)多克隆抗體 Polyclonal Antibody to Glucosidase Alpha, Acid (GaA)
kl585Bo01 細(xì)胞周期素D1(CCND1)多克隆抗體 Polyclonal Antibody to Cyclin D1 (CCND1)
